Tamarand L. Darling

2.4k total citations · 1 hit paper
16 papers, 452 citations indexed

About

Tamarand L. Darling is a scholar working on Infectious Diseases, Animal Science and Zoology and Epidemiology. According to data from OpenAlex, Tamarand L. Darling has authored 16 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 5 papers in Animal Science and Zoology and 4 papers in Epidemiology. Recurrent topics in Tamarand L. Darling's work include SARS-CoV-2 and COVID-19 Research (13 papers), Animal Virus Infections Studies (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Tamarand L. Darling is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), Animal Virus Infections Studies (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Tamarand L. Darling collaborates with scholars based in United States, Japan and Germany. Tamarand L. Darling's co-authors include Adrianus C. M. Boon, Michael Diamond, James Brett Case, Adam L. Bailey, Houda Harastani, Traci L. Bricker, Zhenlu Chong, Robert H. Carnahan, Emma S. Winkler and Richard D. Head and has published in prestigious journals such as Cell, Nature Communications and Nature Immunology.

In The Last Decade

Tamarand L. Darling

15 papers receiving 445 citations

Hit Papers

Human neutralizing antibodies against SARS-CoV-2 require ... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
    2021 183 citations Emma S. Winkler, Pavlo Gilchuk et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamarand L. Darling United States 9 343 130 83 73 69 16 452
Tomer Zohar United States 5 290 0.8× 83 0.6× 76 0.9× 60 0.8× 41 0.6× 5 367
Leah J. Homad United States 7 343 1.0× 79 0.6× 43 0.5× 57 0.8× 105 1.5× 9 417
Matthew D. Slein United States 6 211 0.6× 96 0.7× 54 0.7× 74 1.0× 43 0.6× 9 302
Yu-Hsin Wan United States 5 330 1.0× 84 0.6× 39 0.5× 78 1.1× 110 1.6× 6 396
Christine Dahlke Germany 12 277 0.8× 78 0.6× 111 1.3× 47 0.6× 129 1.9× 31 481
Colin Mann United States 11 258 0.8× 117 0.9× 83 1.0× 101 1.4× 113 1.6× 18 443
Alexander S. Hahn Germany 8 619 1.8× 100 0.8× 106 1.3× 55 0.8× 181 2.6× 18 762
Deleah Pettie United States 5 562 1.6× 78 0.6× 52 0.6× 51 0.7× 134 1.9× 5 654
Juanjie Tang United States 10 282 0.8× 49 0.4× 77 0.9× 34 0.5× 62 0.9× 13 346
Bojan F. Hörnich Germany 5 606 1.8× 75 0.6× 54 0.7× 55 0.8× 170 2.5× 6 701

Countries citing papers authored by Tamarand L. Darling

Since Specialization
Citations

This map shows the geographic impact of Tamarand L. Darling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamarand L. Darling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamarand L. Darling more than expected).

Fields of papers citing papers by Tamarand L. Darling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamarand L. Darling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamarand L. Darling. The network helps show where Tamarand L. Darling may publish in the future.

Co-authorship network of co-authors of Tamarand L. Darling

This figure shows the co-authorship network connecting the top 25 collaborators of Tamarand L. Darling. A scholar is included among the top collaborators of Tamarand L. Darling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamarand L. Darling. Tamarand L. Darling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Darling, Tamarand L., et al.. (2025). Barcoded SARS-CoV-2 viruses define the impact of duration and route of exposure on the transmission bottleneck in a hamster model. Science Advances. 11(3). eads2927–eads2927.
2.
Darling, Tamarand L., Houda Harastani, Astha Joshi, et al.. (2024). Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters. Science Advances. 10(31). eadp1290–eadp1290. 7 indexed citations
3.
Soudani, Nadia, Traci L. Bricker, Tamarand L. Darling, et al.. (2024). Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters. Journal of Virology. 98(10). e0052824–e0052824. 2 indexed citations
4.
Ying, Baoling, Tamarand L. Darling, Pritesh Desai, et al.. (2024). Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection. Nature Immunology. 25(3). 537–551. 18 indexed citations
5.
Jiang, Hongbing, Astha Joshi, Andrew B. Janowski, et al.. (2023). The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2. Journal of Virology. 97(6). e0063523–e0063523. 8 indexed citations
6.
Tsuji, Moriya, Manoj S. Nair, Candace Castagna, et al.. (2023). An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo. Nature Communications. 14(1). 3959–3959. 20 indexed citations
7.
Case, James Brett, Suzanne M. Scheaffer, Tamarand L. Darling, et al.. (2023). Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters. Journal of Virology. 97(9). e0062823–e0062823. 10 indexed citations
8.
Kackos, Christina, Sherri L. Surman, Bart G. Jones, et al.. (2023). mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19. Microbiology Spectrum. 11(1). e0424022–e0424022. 7 indexed citations
9.
Darling, Tamarand L., Baoling Ying, Bradley Whitener, et al.. (2022). mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2. Med. 3(5). 309–324.e6. 6 indexed citations
10.
Boon, Adrianus C. M., Tamarand L. Darling, Peter Halfmann, et al.. (2022). Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters. PLoS Pathogens. 18(12). e1010970–e1010970. 19 indexed citations
11.
Swaim, Caleb D., Varun Dwivedi, Yi-Chieh Perng, et al.. (2021). 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro. iScience. 24(10). 103213–103213. 33 indexed citations
12.
Winkler, Emma S., Pavlo Gilchuk, Jinsheng Yu, et al.. (2021). Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell. 184(7). 1804–1820.e16. 183 indexed citations breakdown →
13.
Bricker, Traci L., Tamarand L. Darling, Ahmed O. Hassan, et al.. (2021). A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters. Cell Reports. 36(3). 109400–109400. 102 indexed citations
14.
Bricker, Traci L., Tamarand L. Darling, Ahmed O. Hassan, et al.. (2021). A Single Intranasal or Intramuscular Immunization with Chimpanzee Adenovirus Vectored SARS-CoV-2 Vaccine Protects Against Pneumonia in Hamsters. SSRN Electronic Journal. 5 indexed citations
15.
Darling, Tamarand L., Adam J. Hume, Robert A. Davey, et al.. (2020). Egyptian Rousette IFN-ω Subtypes Elicit Distinct Antiviral Effects and Transcriptional Responses in Conspecific Cells. Frontiers in Immunology. 11. 435–435. 17 indexed citations
16.
Darling, Tamarand L., Laura J. Sherwood, & Andrew Hayhurst. (2017). Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging. Frontiers in Immunology. 8. 1197–1197. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomer Zohar Breakdown of academic impact, for papers by Leah J. Homad Breakdown of academic impact, for papers by Matthew D. Slein Breakdown of academic impact, for papers by Yu-Hsin Wan Breakdown of academic impact, for papers by Christine Dahlke Breakdown of academic impact, for papers by Colin Mann Breakdown of academic impact, for papers by Alexander S. Hahn Breakdown of academic impact, for papers by Deleah Pettie Breakdown of academic impact, for papers by Juanjie Tang Breakdown of academic impact, for papers by Bojan F. Hörnich
Rankless by CCL
2026